drugset / Trial / NCT03929718

Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation

NCT03929718

Phase 0 Active not recruiting 50 enrolled Piedmont Healthcare
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to accurately determine, using an implantable rhythm monitor, the long-term incidence of new atrial fibrillation after ablation of atrial flutter in those treated with spironolactone compared with standard medical therapy.

Timeline

Start
2019-04-24
Primary completion
2025-09
Completion
2027-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Spironolactone Small molecule Oral

Indications